Southwest Synthetic injection of North medical and pharmaceutical assets trading today
Source: Internet
Author: User
NetEase Financial October 26 suspension has been January Southwest synthesis announced today, will be 14.47 yuan/share of the price to major shareholders-Beida International Hospital Group Non-public issue about 9.26 million shares, the acquisition of its holdings of Beijing North Medical and Pharmaceutical Co., Ltd. 100% Equity, the target assets estimated at about 134 million yuan. The bulletin said that the pharmaceutical industry is founder Group's strategic investment direction, Southwest synthesis as founder Group's only pharmaceutical manufacturing listed companies, is the founder Group pharmaceutical industry integration platform. The rapid development of pharmaceutical economy and industrial policy prompted founder Group to accelerate the pace of industrial integration, and enlarge the pharmaceutical sector of founder Group. Data show that last year Southwest synthesis to founder Group's Peking University International Hospital group directed to issue shares, purchase its holdings of Chongqing Daxin Pharmaceutical Co., Ltd. 90.63% of the equity. After the completion of the reorganization of the assets, Southwest Synthesis has covered the founder group's raw materials, pharmaceutical production of high-quality core assets. The targeted additional acquisition of the North Medical and Pharmaceutical and its subsidiary Leaf Kai Tai Technology is founder Group's important pharmaceutical logistics sales platform, relying on the abundant resources of Peking University Medical department, founder Group and Peking University International Hospital group, North Medical Medicine has already had an experienced and professional excellent management team and sales team, which has formed a foothold in Beijing, Radiation three provinces, Shandong, Hebei, Tianjin and other provinces and cities stable Channel network, with high-quality, stable suppliers and customers. This January-September, the North Medical and pharmaceutical business income of 373 million yuan, net profit of 12.75 million yuan. Southwest Synthesis Today open trading, reported 16.23 yuan, the whole day has not opened, deal 281 million yuan, change hand rate of 7.12%.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.